Microvascular and macrovascular effects of liraglutide

Int J Cardiol. 2019 Jul 1:286:17-18. doi: 10.1016/j.ijcard.2019.02.041. Epub 2019 Feb 25.

Authors

Domenico Cianflone¹, Ali A Rizvi², Manfredi Rizzo³

Affiliations

¹ San Raffaele Vita-Salute University, Milan, Italy.
² Division of Endocrinology, Diabetes and Metabolism, School of Medicine, University of South Carolina, USA.
³ Division of Endocrinology, Diabetes and Metabolism, School of Medicine, University of South Carolina, USA; PROMISE Department, School of Medicine, University of Palermo, Italy. Electronic address: manfredi.rizzo@unipa.it.

PMID: 30878237
DOI: 10.1016/j.ijcard.2019.02.041

No abstract available

Publication types

Editorial
Comment

MeSH terms

Diabetes Mellitus, Type 2*
Female
Humans
Hypoglycemic Agents
Liraglutide*
Overweight

Substances

Hypoglycemic Agents
Liraglutide